0001203311-20-000051.txt : 20200519
0001203311-20-000051.hdr.sgml : 20200519
20200519191115
ACCESSION NUMBER: 0001203311-20-000051
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200515
FILED AS OF DATE: 20200519
DATE AS OF CHANGE: 20200519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Simonian Nancy A
CENTRAL INDEX KEY: 0001359574
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 20895248
MAIL ADDRESS:
STREET 1: C/O SYROS PHARMACEUTICALS, INC.
STREET 2: 620 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-05-15
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001359574
Simonian Nancy A
21823 30TH DRIVE SE
BOTHELL
WA
98021
1
0
0
0
Common Stock
2020-05-15
4
A
0
1335
0.0
A
26098
D
Non-Qualified Stock Option (right to buy)
160.33
2020-05-15
4
A
0
3171
0.0
A
2021-05-15
2030-05-15
Common Stock
3171
3171
D
These restricted stock units will be settled in common stock upon vesting.
These restricted stock units shall vest in full on May 15, 2021.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
By: /s/ Jean Liu For: Nancy A. Simonian
2020-05-19